Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Oppenheimer Downgrades Stellus Cap Investment to Perform, Announces $15 Price Target

Author: Benzinga Newsdesk | August 14, 2023 06:54am
Oppenheimer analyst Mitchel Penn downgrades Stellus Cap Investment (NYSE:SCM) from Outperform to Perform and announces $15 price target.

Posted In: SCM